查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1462978

透皮給藥系統市場、佔有率、規模、趨勢、產業分析報告：依類型、技術、應用、地區、細分市場預測，2024-2032 年

Transdermal Drug Delivery Systems Market Share, Size, Trends, Industry Analysis Report, By Type (Transdermal Patches, Transdermal Semisolids); By Technology; By Application; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球透皮給藥系統市場規模預計將達到400.1億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

醫療保健支出的增加和對替代藥物輸送方法的認識不斷提高正在推動透皮藥物輸送系統市場的發展。 隨著全球醫療保健支出的增加，對改善患者治療效果的經濟有效的治療方法的需求日益增長。 透皮給藥系統因其優於傳統方法而受到關注。 透皮給藥系統可以提供受控和持續的藥物釋放，提高療效並最大限度地減少副作用。 非侵入性、無痛的透皮貼片為患者提供舒適感和藥物順從性。

無需處方即可獲得的 OTC（非處方）藥物越來越多地用於自我治療小病。 由於方便的藥物選擇和不斷增長的自我照護需求，非處方藥市場正在經歷強勁成長。 透皮給藥系統在非處方藥領域具有優勢，例如易於使用和副作用較少。 消費者可以在家中輕鬆使用該貼劑，這與非處方藥市場強調可靠和方便的治療選擇是一致的。 隨著消費者意識的提高和更多產品的出現，對透皮給藥系統的需求預計將會增加。

對透皮激素替代療法 (HRT) 的偏好正在推動透皮給藥系統市場的發展。 透皮激素替代療法通常用於緩解更年期症狀，與傳統方法相比具有優勢。 透皮貼片直接透過皮膚輸送激素，繞過消化和肝臟代謝，從而穩定激素水平並減少副作用。 方便且易於使用的貼片消除了頻繁就診的需要，並鼓勵患者依從性。 由於它們謹慎且舒適，因此受到患者和醫療保健提供者的歡迎。

由於皮膚科和化妝品領域應用的不斷擴大，透皮給藥系統市場正在不斷成長。 針對牛皮癬和痤瘡等疾病，最大限度地減少全身副作用。 此外，透皮貼片在藥妝品中越來越受歡迎，以提供抗氧化劑和維生素等護膚成分。 這些貼片可確保控制釋放並對皮膚產生持久的影響。 皮膚病患病率上升、消費者對皮膚護理意識的增強以及對非侵入性給藥方法的需求等因素正在推動市場成長。

透皮給藥系統市場報告重點

2023 年，由於易用性、便利性和患者依從性，透皮貼片產業佔了很大的收入佔有率。

2023年，由於高效的藥物傳遞、增強的吸收和擴大的臨床應用，離子電滲透療法領域佔了很大的收入佔有率。

2023 年，由於慢性疼痛的發生率不斷增加、針對性治療和患者偏好，疼痛管理領域佔了很大的收入佔有率。

2023年，北美地區憑藉先進的醫療基礎設施、高昂的醫療成本以及主要市場參與者的存在，在全球市場中佔主導地位。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第四章全球透皮給藥系統市場洞察

  • 透皮給藥系統市場 - 應用快照
  • 透皮給藥系統的市場動態
    • 推動者和機會
      • 由於慢性病盛行率不斷上升，對該產品的需求預計將會增加。
      • 人口老化預計將推動透皮給藥系統市場的成長
    • 抑制因素和課題
      • 監管和合規要求可能會阻礙市場成長
  • PESTEL 分析
  • 透皮給藥系統市場的應用趨勢
  • 價值鏈分析
  • 新冠肺炎 (COVID-19) 影響分析

第五章依科技劃分的世界市場

  • 主要發現
  • 簡介
  • 離子電滲透療法
  • 電穿孔
  • 超音波
  • 機械陣列
  • 其他

第 6 章世界市場（依類型）

  • 主要發現
  • 簡介
  • 透皮貼劑
  • 透皮吸收半固體藥物

第 7 章依應用劃分的世界市場

  • 主要發現
  • 簡介
  • 疼痛管理
  • 荷爾蒙的應用
  • 心血管疾病
  • 中樞神經系統疾病
  • 其他

第 8 章依地區劃分的世界市場

  • 主要發現
  • 簡介
    • 2019-2032 年經皮給藥系統市場評估（依地區）
  • 透皮給藥系統市場 - 北美
    • 北美：透皮給藥系統市場（依技術），2019-2032 年
    • 北美：透皮給藥系統市場，依應用劃分，2019-2032 年
    • 北美：透皮給藥系統市場（依類型），2019-2032 年
    • 經皮給藥系統市場 - 美國
    • 透皮給藥系統市場 - 加拿大
  • 透皮給藥系統市場 - 歐洲
    • 歐洲：透皮給藥系統市場（依技術），2019-2032 年
    • 歐洲：透皮給藥系統市場，依應用劃分，2019-2032 年
    • 歐洲：透皮給藥系統市場（依類型），2019-2032 年
    • 透皮給藥系統市場 - 英國
    • 透皮給藥系統市場 - 法國
    • 透皮給藥系統市場 - 德國
    • 透皮給藥系統市場 - 義大利
    • 透皮給藥系統市場 - 西班牙
    • 透皮給藥系統市場 - 荷蘭
    • 透皮給藥系統市場 - 俄羅斯
  • 透皮給藥系統市場 - 亞太地區
    • 亞太地區：透皮給藥系統市場（依技術），2019-2032 年
    • 亞太地區：透皮給藥系統市場，依應用劃分，2019-2032 年
    • 亞太地區：透皮給藥系統市場（依類型），2019-2032 年
    • 透皮給藥系統市場 - 中國
    • 透皮給藥系統市場 - 印度
    • 經皮給藥系統市場 - 馬來西亞
    • 透皮給藥系統市場 - 日本
    • 透皮給藥系統市場 - 印尼
    • 透皮給藥系統市場 - 韓國
  • 透皮給藥系統市場 - 中東和非洲
    • 中東和非洲：透皮給藥系統市場（依技術），2019-2032 年
    • 中東和非洲：透皮給藥系統市場，依應用劃分，2019-2032 年
    • 中東和非洲：透皮給藥系統市場（依類型），2019-2032 年
    • 透皮給藥系統市場 - 沙烏地阿拉伯
    • 透皮給藥系統市場 - 阿聯酋
    • 透皮給藥系統市場 - 以色列
    • 透皮給藥系統市場 - 南非
  • 透皮給藥系統市場 - 拉丁美洲
    • 拉丁美洲：透皮給藥系統市場（依技術），2019-2032 年
    • 拉丁美洲：透皮給藥系統市場，依應用劃分，2019-2032 年
    • 拉丁美洲：透皮給藥系統市場（依類型），2019-2032 年
    • 透皮給藥系統市場 - 墨西哥
    • 透皮給藥系統市場 - 巴西
    • 透皮給藥系統市場 - 阿根廷

第九章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 合作/協作/合約/出版物

第十章公司簡介

  • 3M Company
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy's Laboratories Ltd.
  • Endo Pharmaceuticals Inc
  • GlaxoSmithKline plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • MedPharm Ltd.
  • Mylan N.V.
  • Novartis International AG
  • Noven Pharmaceuticals, Inc.
  • Purdue Pharma L.P
  • Teva Pharmaceutical Industries Ltd.
  • UCB S.A.
Product Code: PM4660

The global transdermal drug delivery systems market size is expected to reach USD 40.01 billion by 2032, according to a new study by Polaris Market Research. The report "Transdermal Drug Delivery Systems Market Share, Size, Trends, Industry Analysis Report, By Type (Transdermal Patches, Transdermal Semisolids); By Technology; By Application; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising healthcare spending and heightened awareness of alternative drug delivery methods are propelling the transdermal drug delivery systems market. With increasing global healthcare expenditures, there's a growing need for cost-effective treatments offering improved patient outcomes. Transdermal drug delivery systems are gaining traction for their advantages over conventional methods. They provide controlled, sustained medication release, enhancing efficacy and minimizing side effects. Non-invasive and painless, transdermal patches offer patient comfort and adherence.

OTC (Over-the-Counter) medications, available without a prescription, are increasingly preferred for self-treating minor ailments. With rising demand for convenient medication options and self-care, the OTC market is witnessing robust growth. Transdermal drug delivery systems offer advantages in the OTC sector, including ease of use and minimal side effects. Consumers can conveniently apply patches at home, aligning with the OTC market's focus on reliable and convenient treatment options. As consumer awareness increases and more products become available, the demand for transdermal drug delivery systems is expected to rise.

The preference for transdermal hormone replacement therapy (HRT) is driving the transdermal drug delivery systems market. Commonly used to alleviate menopausal symptoms, transdermal HRT offers advantages over traditional methods. Transdermal patches deliver hormones directly through the skin, bypassing the digestive system and liver metabolism, resulting in stable hormone levels and reduced side effects. Convenient and easy to use, patches promote patient compliance by eliminating frequent healthcare visits. Discreet and comfortable, they are increasingly popular among patients and healthcare providers.

The transdermal drug delivery systems market is growing due to expanding applications in dermatology and cosmeceuticals. It targets conditions like psoriasis and acne, minimizing systemic side effects. Additionally, transdermal patches are increasingly popular in cosmeceuticals for delivering skincare ingredients such as antioxidants and vitamins. These patches ensure controlled release, providing prolonged skin benefits. Factors like the rising prevalence of skin disorders, increasing consumer awareness about skincare, and demand for non-invasive drug delivery methods are driving the growth of the market.

Transdermal Drug Delivery Systems Market Report Highlights

In 2023, the transdermal patches segment held a significant revenue share owing to ease of use, convenience, and patient compliance.

In 2023, the iontophoresis segment held a significant revenue share owing to efficient drug delivery, enhanced absorption, and growing clinical adoption.

In 2023, the pain management segment held a significant revenue share owing to the growing incidence of chronic pain, targeted delivery, and patient preference.

In 2023, the North America region dominated the global market due to advanced healthcare infrastructure, high healthcare expenditure, and the presence of key market players.

The market is highly competitive owing to the existence of market players with a global presence, including Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, MedPharm Ltd., Novartis International AG, and Purdue Pharma L.P. among others.

Polaris Market Research has segmented the Transdermal Drug Delivery Systems market report based on type, technology, application, and region:

Transdermal Drug Delivery Systems, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Transdermal Patches
  • Transdermal Semisolids

Transdermal Drug Delivery Systems, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

  • Iontophoresis
  • Electroporation
  • Ultrasound
  • Mechanical arrays
  • Others

Transdermal Drug Delivery Systems, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pain Management
  • Hormonal Applications
  • Cardiovascular Diseases
  • CNS Disorders
  • Others

Transdermal Drug Delivery Systems, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Transdermal Drug Delivery Systems Market Insights

  • 4.1. Transdermal Drug Delivery Systems Market - Application Snapshot
  • 4.2. Transdermal Drug Delivery Systems Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising prevalence of chronic diseases is projected to spur the product demand
      • 4.2.1.2. Growing Geriatric Population is expected to drive transdermal drug delivery systems market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory and compliance requirements are likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Transdermal Drug Delivery Systems Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Transdermal Drug Delivery Systems Market, by Technology

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • 5.3. Iontophoresis
    • 5.3.1. Global Transdermal Drug Delivery Systems Market, by Iontophoresis, by Region, 2019-2032 (USD Billion)
  • 5.4. Electroporation
    • 5.4.1. Global Transdermal Drug Delivery Systems Market, by Electroporation, by Region, 2019-2032 (USD Billion)
  • 5.5. Ultrasound
    • 5.5.1. Global Transdermal Drug Delivery Systems Market, by Ultrasound, by Region, 2019-2032 (USD Billion)
  • 5.6. Mechanical arrays
    • 5.6.1. Global Transdermal Drug Delivery Systems Market, by Mechanical arrays, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Transdermal Drug Delivery Systems Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Transdermal Drug Delivery Systems Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • 6.3. Transdermal Patches
    • 6.3.1. Global Transdermal Drug Delivery Systems Market, by Transdermal Patches, by Region, 2019-2032 (USD Billion)
  • 6.4. Transdermal Semisolids
    • 6.4.1. Global Transdermal Drug Delivery Systems Market, by Transdermal Semisolids, by Region, 2019-2032 (USD Billion)

7. Global Transdermal Drug Delivery Systems Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Pain Management
    • 7.3.1. Global Transdermal Drug Delivery Systems Market, by Pain Management, By Region, 2019-2032 (USD Billion)
  • 7.4. Hormonal Applications
    • 7.4.1. Global Transdermal Drug Delivery Systems Market, by Hormonal Applications, By Region, 2019-2032 (USD Billion)
  • 7.5. Cardiovascular Diseases
    • 7.5.1. Global Transdermal Drug Delivery Systems Market, by Cardiovascular Diseases, By Region, 2019-2032 (USD Billion)
  • 7.6. CNS Disorders
    • 7.6.1. Global Transdermal Drug Delivery Systems Market, by CNS Disorders, By Region, 2019-2032 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Transdermal Drug Delivery Systems Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Transdermal Drug Delivery Systems Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Transdermal Drug Delivery Systems Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Transdermal Drug Delivery Systems Market - North America
    • 8.3.1. North America: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
    • 8.3.2. North America: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
    • 8.3.3. North America: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.3.4. Transdermal Drug Delivery Systems Market - U.S.
      • 8.3.4.1. U.S.: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.3.5. Transdermal Drug Delivery Systems Market - Canada
      • 8.3.5.1. Canada: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • 8.4. Transdermal Drug Delivery Systems Market - Europe
    • 8.4.1. Europe: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.4.4. Transdermal Drug Delivery Systems Market - UK
      • 8.4.4.1. UK: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.4.5. Transdermal Drug Delivery Systems Market - France
      • 8.4.5.1. France: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.4.6. Transdermal Drug Delivery Systems Market - Germany
      • 8.4.6.1. Germany: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.4.7. Transdermal Drug Delivery Systems Market - Italy
      • 8.4.7.1. Italy: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.4.8. Transdermal Drug Delivery Systems Market - Spain
      • 8.4.8.1. Spain: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.4.9. Transdermal Drug Delivery Systems Market - Netherlands
      • 8.4.9.1. Netherlands: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.4.10. Transdermal Drug Delivery Systems Market - Russia
      • 8.4.10.1. Russia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • 8.5. Transdermal Drug Delivery Systems Market - Asia Pacific
    • 8.5.1. Asia Pacific: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.5.4. Transdermal Drug Delivery Systems Market - China
      • 8.5.4.1. China: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.5.5. Transdermal Drug Delivery Systems Market - India
      • 8.5.5.1. India: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.5.6. Transdermal Drug Delivery Systems Market - Malaysia
      • 8.5.6.1. Malaysia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.5.7. Transdermal Drug Delivery Systems Market - Japan
      • 8.5.7.1. Japan: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.5.8. Transdermal Drug Delivery Systems Market - Indonesia
      • 8.5.8.1. Indonesia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.5.9. Transdermal Drug Delivery Systems Market - South Korea
      • 8.5.9.1. South Korea: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • 8.6. Transdermal Drug Delivery Systems Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.6.4. Transdermal Drug Delivery Systems Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.6.5. Transdermal Drug Delivery Systems Market - UAE
      • 8.6.5.1. UAE: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.6.6. Transdermal Drug Delivery Systems Market - Israel
      • 8.6.6.1. Israel: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.6.7. Transdermal Drug Delivery Systems Market - South Africa
      • 8.6.7.1. South Africa: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • 8.7. Transdermal Drug Delivery Systems Market - Latin America
    • 8.7.1. Latin America: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.7.4. Transdermal Drug Delivery Systems Market - Mexico
      • 8.7.4.1. Mexico: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.7.5. Transdermal Drug Delivery Systems Market - Brazil
      • 8.7.5.1. Brazil: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.7.6. Transdermal Drug Delivery Systems Market - Argentina
      • 8.7.6.1. Argentina: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. 3M Company
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bayer AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Boehringer Ingelheim International GmbH
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Dr. Reddy's Laboratories Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Endo Pharmaceuticals Inc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. GlaxoSmithKline plc
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Hisamitsu Pharmaceutical Co., Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Johnson & Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. MedPharm Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Mylan N.V.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Novartis International AG
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Noven Pharmaceuticals, Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Purdue Pharma L.P
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Teva Pharmaceutical Industries Ltd.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. UCB S.A.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables

  • Table 1 Global Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 2 Global Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 3 Global Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 4 Transdermal Drug Delivery Systems Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 6 North America: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 7 North America: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 8 U.S.: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 9 U.S.: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 11 Canada: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 12 Canada: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 13 Canada: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 14 Europe: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 15 Europe: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Europe: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 17 UK: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 18 UK: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 19 UK: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 20 France: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 21 France: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 22 France: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 23 Germany: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 24 Germany: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 26 Italy: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 27 Italy: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 28 Italy: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 29 Spain: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 30 Spain: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 31 Spain: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 35 Russia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 36 Russia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 37 Russia: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 41 China: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 42 China: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 43 China: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 44 India: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 45 India: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 46 India: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 50 Japan: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 51 Japan: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Japan: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 56 South Korea: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 57 South Korea: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 58 South Korea: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 65 UAE: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 66 UAE: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 67 UAE: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 68 Israel: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 69 Israel: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 70 Israel: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 71 South Africa: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 72 South Africa: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 73 South Africa: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 74 Latin America: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 75 Latin America: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 76 Latin America: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 77 Mexico: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 78 Mexico: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 79 Mexico: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 80 Brazil: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 81 Brazil: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 83 Argentina: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 84 Argentina: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 85 Argentina: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Transdermal Drug Delivery Systems Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Transdermal Drug Delivery Systems Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Technology
  • Figure 9. Global Transdermal Drug Delivery Systems Market, by Technology, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Transdermal Drug Delivery Systems Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 12. Transdermal Drug Delivery Systems Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Transdermal Drug Delivery Systems Market